cerrar
Tagged with disease

Sean Richardson – GM, Alexion Pharma UK
Sean Richardson discusses Alexion’s focus on rare and ultra-rare diseases, the level of support for these therapies from the UK government,…

K P Tsang, President, Hong Kong Alliance for Rare Diseases…
K P Tsang, president of the Hong Kong Alliance for Rare Diseases (HKARD), shares the challenges faced by patients with rare diseases and their…

Neil Dugdale – VP & GM, UK & RoI, Sobi
Three years into his role as general manager of Sobi’s UK and Republic of Ireland operations, Neil Dugdale introduces the scope of operations of the…

Interview: Alba Ancochea – Director, FEDER, Spain
Alba Ancochea of FEDER, the association that groups together Spain’s 337 rare disease patient organizations, explains how it interacts with both…

Interview: Alicia Folgueira López – General Manager Spain…
Alnylam, pioneers in the RNA interference field, seek to bring their revolutionary medicine across Europe, and in particular Portugal before 2020. In…

José Manuel Rigueiro – General Manager, Actelion Spain
Jose Manuel Rigueiro, general manager of the Spanish affiliate of Actelion, discusses the lack of trust between health authorities and the industry…

Interview: Carla Benedito – General Manager, Shire Portugal
Carla Benedito, general manager of Shire Portugal, provides useful insight into the rare diseases landscape in Portugal. Carla discusses market access…

Interview: Bryan Morton CBE – Executive Chairman and…
With an appetite to take the next step in its rapid development, EUSA Pharma has already established itself as a leading rare-disease and oncology…

Bob McLay – Vice President and General Manager, Sobi Canada
Bob McLay, vice president and general manager of Sobi in Canada, discusses how innovation and collaboration with regulators and payers are helping…

Swati Jajodia – Managing Director, Swati Spentose, India
Swati Jajodia, managing director of Swati Spentose discusses her commitment to tackling underserved diseases and the company’s approach to bringing…

Interview: Brian Canestraro – General Manager, Intercept,…
Looking back on three years of operations in Canada and nine months of approval of Ocaliva® for the rare non-viral liver disease PBC, Brian…

Cardiology in Poland: Building a Leading Ecosystem
"From the perspective of a cardiologist working everyday with patients, we have experienced positive change and drastic improvements over the last 20…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here